HBV Mutation Detail Information

> V173L Search Result


Mutation Information
Mutation Site V173L
Mutation Type Amino acid level
Gene/Protein/Region Type RT
Combined Mutation rt.M204V+rt.L180M+rt.V173L;rt.M204V+rt.S202G+rt.L180M+rt.P177S+rt.V173L
Relevant Drug lamivudine (LAM);entecavir (ETV)
Literature Information
PubMed PMID 17239478
Disease Chronic hepatitis B; Liver cirrhosis
Published Year 2007
Journal Journal of hepatology
Title Stepwise process for the development of entecavir resistance in a chronic hepatitis B virus infected patient.
Author Villet S,Ollivet A,Pichoud C,Barraud L,Villeneuve JP,Trépo C,Zoulim F
Evidence The rtV173L+L180M+M204V dominant mutant displayed strong lamivudine-resistance and the highest replication capacity.

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation